Euglena Co., Ltd. (TYO:2931)

Market Cap	48.27B -23.2%
Revenue (ttm)	52.32B +7.8%
Net Income	-173.00M
EPS	-1.26
Shares Out	139.50M
PE Ratio	n/a
Forward PE	91.05
Dividend	2.00 (0.58%)
Ex-Dividend Date	Dec 29, 2025

Volume	514,500
Open	342.00
Previous Close	343.00
Day's Range	341.00 - 346.00
52-Week Range	318.00 - 468.00
Beta	-0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Euglena

Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It operates through there segments: Healthcare Business; Biofuel Business; and Other businesses. The company manufactures and sells health foods and cosmetics utilizing microalgae, such as euglena and chlorella. In addition, the company develops biofuel technology and environmental related technology for microalgae and industrial waste oil; development and research in agriculture business comprising feed and fertilizer, bioinformatics, and socia...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2005
• Employees: 793
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2931

Financial Performance

In 2025, Euglena's revenue was 50.37 billion, an increase of 5.78% compared to the previous year's 47.62 billion. Losses were -805.00 million, 23.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 10, 2026

Data Sources Report a data error